Budget 2026-27 में Cancer Meds से Customs Duty हटी, BioPharma Shakti, आपकी Health के लिए और क्या है?

39 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Experts on Health Budget 2026-27: Will the Health Budget 2026–27 translate into real, on-ground relief for patients? How significant is the removal of basic customs duty on 17 cancer drugs for treatment affordability? Will exempting rare disease medicines and special medical foods from customs duty meaningfully reduce patient costs? How impactful is the ‘BioPharma Shakti’ initiative in making India a global biopharma hub? Will expanding AIIMS, NIPERs, and mental health institutes strengthen healthcare access across regions? How will investments in medical infrastructure and allied health professionals improve overall quality of care? Guest: Dr. Kunjahari Medhi, Senior Director, Medical Oncology, Cancer Care, Medanta. And, Dr. Anil Thakwani, Senior Consultant & HOD, Radiation Oncology, Sharda Care Healthcity.

#health #UnionBudget #healthbudget

The copyright ownership in the video rests with India Today Group. No third party is permitted to use the video without obtaining the permission of India Today Group. Any permission for usage can be obtained through the email ID provided here: [email protected].

न्यूज़ लेटर के लिए क्लिक करें : https://www.thelallantop.com/newsletter

खबरों को विस्तार से पढ़ने के लिए क्लिक करें यहां : https://www.thelallantop.com/

Instagram: @thelallantop
Facebook: @thelallantop
Twitter: @TheLallantop

Production: Aditi Agnihotri
Video Editor: Shubham
Categoria
Oncology
Commenta per primo questo video.

Prossimo